¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hyperparathyroidism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® hyperparathyroidism ÇÑ±Û ºÎ°©»ó»ù±â´ÉÇ×ÁøÁõ
¼³¸í   
  ºÎ°©»ó»ù È£¸£¸óÀÇ ºÐºñ°¡ ¸¹¾ÆÁ® Àִ »óŸ¦ ¸»ÇÑ´Ù. ºÎ°©»ó»ù È£¸£¸óÀº Ç÷Áß¿¡ Ä®½·ÀÇ ³óµµ¸¦ ³ôÀ̴ ¿ªÇÒÀ» ÇÑ´Ù. Áï »À¼Ó¿¡ µé¾îÀִ Į½·À» ºÐÇØÇÏ¿© Ç÷ÁßÀ¸·Î ³»º¸³»°í ÄáÆÏ¿¡ ÀÛ¿ëÀ» ÇÏ¿©¼­ ¿ÀÁÜÀ¸·Î Ã¼¿Ü·Î ¹è¼³µÇ´Â Ä®½·ÀÇ ÀçÈí¼ö¸¦ ÃËÁø½ÃŰ°í ¼ÒÈ­°ü¿¡¼­ Ä®½·ÀÇ Èí¼ö¸¦ ÃËÁø½ÃŲ´Ù. ÁַΠºÎ°©»ó¼±ÀÇ ¾Ï¿¡ ÀÇÇÏ¿© ¸¹Àº ºÎ°©»ó¼± È£¸£¸óÀÌ »ý¼ºµÇ´Â °ÍÀÌ ÁÖ ¿øÀÎÀ̰í, ¾ÏÀÇ »ý¼º¾øÀÌ ºÎ°©»ó»ù È£¸£¸óÀ» °ú»ý»êÇϴ °æ¿ìµµ ÀÖ´Ù. ¶§·Î´Â ´Ù¸¥ ¾ÏµéÀÌ ÀÌ ºÎ°©»ó»ùÈ£¸£¸óÀ» ºÐºñÇÏ¿©¼­ ºÎ°©»ó»ù±â´ÉÇ×ÁøÁõÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù. Áõ»óÀº À§Ã¢ÀÚÁõ¼¼(±¸¿ªÁú, ±¸Åä, º¯ºñ, ½Ä¿åºÎÁø), ÁßÃ߽ŰæÁõ¼¼(¹«°ü½É, ¿ì¿ï, ±â¾ï·Â°¨Åð, ÀǽĠȥµ¿), ½Å°æ ±ÙÀ°Áõ¼¼(ÇÇ·Î, ±Ù·ÂÀúÇÏ) µîÀÌ ³ªÅ¸³ª°í °Ë»ç¼Ò°ßÀº Ç÷û Ä®½·ÀÌ »ó½ÂµÇ¾î ÀÖ°í(>12mg/dL), Ç÷û ÀÎÀº °¨¼Ò(<3mg/dL)µÇ¾î ÀÖ´Ù. ÄáÆÏ, Àδ령נ¿¬°ñ µî ¿¬ºÎÁ¶Á÷ÀÇ Ä®½·Ä§ÂøÀ» ÀÏÀ¸Å²´Ù. Ä¡·á´Â ºÎ°©»ó»ùÁ¾ÀÌ ÀÖÀ¸¸é ¿Ü°úÀûÀ¸·Î ¶¼¾î³»°í, ºÎ°©»ó»ù°ú´ÙÇü¼º¿¡ ´ëÇØ¼­´Â ºÎºÐÀýÁ¦¸¦ ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó»ùÇ×ÁøÁõ, ºÎ°©»ó¼±Ç×ÁøÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó»ùÇ×ÁøÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hyperparathyroidism
    ºÎ°©»ó¼±Ç×ÁøÁõ(ÜùË£ßÒàÍùñòäñø)
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ(ÜùË£ßÒàÍѦÒöùñòäñø)
  • hyperparathyroidism =parathyreosis
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ(ÜùË£ßÒàÍѦÒöùñòäñø)
  • hyperparathyroidism =parathyreosis
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • brown tumor, hyperparathyroidism
    °¥»öÁ¾¾ç, ºÎ°©»ó¼±±â´É Ç×ÁøÁõ(ÜùË£ßÒàÍѦÒö ùñòäñø)
  • ectopic hyperparathyroidism
    À̼Ҽº ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ.
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(¼Ó¹ß¼ººÎ°©»ó ¼±±â´ÉÇ×ÁøÁõ).
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(áÙÛ¡àõÜùË£ßÒ àÍѦÒöùñòäñø).
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(áÙÛ¡àõÜùË£ßÒàÍѦÒöùñòäñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
HPT histamine provocation test; human placental thyrotropin; hyperparathyroidism; hypothalamo-pituitary-...
HRPT hyperparathyroidism
NSHPT neonatal severe hyperparathyroidism
NSPH neonatal severe hyperparathyroidism
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPT Hyperparathyroidism
NSHPT Neonatal severe hyperparathyroidism
PHP Primary Hyperparathyroidism
PHPT Primary hyperparathyroidism
H-PTH hyperparathyroidism
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • E21
    Hyperparathyroidism and other disorders of parathyroid gland
    ºÎ°©»ó»ù ±â´ÉÇ×ÁøÁõ ¹× ºÎ°©»ó»ùÀÇ ±âŸ Àå¾Ö
  • E21.3
    Hyperparathyroidism, unspecified
    »ó¼¼ºÒ¸íÀÇ ºÎ°©»ó»ù ±â´ÉÇ×ÁøÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hyperparathyroidism
    ºÎ°©»ó¼± ±â´É Ç×ÁøÁõ
    µ¿ÀǾî=
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ectopic hyperparathyroidism
    À̼Ҽº ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×Áø, ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×ÁøÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
hyperparathyroidism The over production of parathormone by the parathyroid glands. Usually secondary to an adenoma (an unregulated glandular tumour that produces parathormone in an increased quantity). Laboratory studies show an elevated calcium in the blood. most patients are without symptoms. Symptoms in more advanced cases include lethargy, confusion, nausea, bone pain and weakness. Findings include hypertension and slow heart rate. Complications include pancreatitis, peptic ulcer disease and kidney stones.
(27 Sep 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
primary hyperparathyroidism Hyperparathyroidism due to neoplasms or idiopathic hyperplasia of the parathyroid glands.
(05 Mar 2000)
secondary hyperparathyroidism Hyperparathyroidism that arises as a result of disordered metabolism producing hypocalcaemia, as in chronic uraemia due to renal disease, malabsorption, rickets, or osteomalacia; associated with hyperplasia of the parathyroid glands.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 3 ÆäÀÌÁö: 1
  • Hyperparathyroidism - »õâ A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
    Synonyms :
  • Hyperparathyroidism, Primary - »õâ A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.
    Synonyms : Primary Hyperparathyroidism, Hyperparathyroidisms, Primary, Primary Hyperparathyroidisms
  • Hyperparathyroidism, Secondary - »õâ Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
    Synonyms : Secondary Hyperparathyroidism, Hyperparathyroidisms, Secondary, Secondary Hyperparathyroidisms
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
hyperparathyroidism excessive secretion of parathyroid hormone resulting in abnormally high levels of calcium in the blood; can affect many systems of the body (especially causing bone resorption and osteoporosis)
Ãâó: wordnet.princeton.edu/perl/webwn
hyperparathyroidism A condition in which the body produces excessive amounts of parathyroid hormone (PTH) disrupting the regulation of calcium. As a result, calcium is taken from the bones; blood levels of calcium rise; and increased amounts of calcium may be excreted in urine
Ãâó: www.everybody.co.nz/page-bfd51fe5-7fd7-43ad-9d3d-3...
hyperparathyroidism Uncontrolled, excessive secretion of the parathyroid ;lands, producing a disease characterized by loss of calcium from the bones. Often resulting in high serum calcium levels and kidney stones.
Ãâó: www.kidneystonesbook.net/glossary.html
hyperparathyroidism A condition marked by over production of the hormone parathormone by the parathyroid glands. These glands are located next to the thyroid gland in the neck. High levels of parathormone result in high blood levels of calcium that the kidneys must excrete. This condition can contribute to the formation of kidney stones.
Ãâó: www.kidneystonecenter-rm.com/treatment/glossary.ht...
hyperparathyroidism Excessive secretion of parathyroid hormone by 1 or more of the 4 parathyroid glands.
Ãâó: www.phosphoruscontrol.com/Glossary.aspx
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
hyperparathyroidism excessive secretion of parathyroid hormone resulting in abnormally high levels of calcium in the blood
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á